{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:36:37Z","timestamp":1760240197247,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,11]]},"DOI":"10.7759\/cureus.94344","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:41Z","timestamp":1760186561000},"source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Study for the Evaluation of Serum Anti-M\u00fcllerian Hormone and Its Correlation With Insulin Resistance and Lipid Profile in Polycystic Ovary Syndrome in Adolescents"],"prefix":"10.7759","author":[{"given":"Tahsina","family":"Begum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ashwini","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naaz","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorjahan","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Gollapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz R","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al.. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016, 2:16057. 10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif A","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18:774-800. 10.1210\/edrv.18.6.0318","journal-title":"Endocr Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-92. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018, 33:1602-18. 10.1093\/humrep\/dey256","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-M\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny P","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-M\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:941-5. 10.1210\/jc.2005-2076","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale HF","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011, 95:1048-58.e1-2. 10.1016\/j.fertnstert.2010.11.036","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1030353","article-title":"Editorial: polycystic ovary syndrome (PCOS): mechanism and management","volume":"13","author":"Wang Y","year":"2022","unstructured":"Wang Y, Leung P, Li R, Wu Y, Huang H. Editorial: polycystic ovary syndrome (PCOS): mechanism and management. Front Endocrinol (Lausanne). 2022, 13:1030353. 10.3389\/fendo.2022.1030353","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0614","article-title":"Fatty liver index in polycystic ovary syndrome","volume":"165","author":"Lerchbaum E","year":"2011","unstructured":"Lerchbaum E, Gruber HJ, Schwetz V, Giuliani A, M\u00f6ller R, Pieber TR, Obermayer-Pietsch B. Fatty liver index in polycystic ovary syndrome. Eur J Endocrinol. 2011, 165:935-43. 10.1530\/EJE-11-0614","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.977","article-title":"Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study","volume":"7","author":"Cutler DA","year":"2019","unstructured":"Cutler DA, Pride SM, Cheung AP. Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study. Food Sci Nutr. 2019, 7:1426-37. 10.1002\/fsn3.977","journal-title":"Food Sci Nutr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1613640","article-title":"Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study","volume":"35","author":"Gupta M","year":"2019","unstructured":"Gupta M, Yadav R, Mahey R, Agrawal A, Upadhyay A, Malhotra N, Bhatla N. Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study. Gynecol Endocrinol. 2019, 35:970-3. 10.1080\/09513590.2019.1613640","journal-title":"Gynecol Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly D","year":"2014","unstructured":"Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014, 20:334-52. 10.1093\/humupd\/dmt061","journal-title":"Hum Reprod Update"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer SL","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014, 20:688-701. 10.1093\/humupd\/dmu020","journal-title":"Hum Reprod Update"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman RJ","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007, 370:685-97. 10.1016\/S0140-6736(07)61345-2","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-Part 1","volume":"21","author":"Goodman NF","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-Part 1. Endocr Pract. 2015, 21:1291-300. 10.4158\/EP15748.DSC","journal-title":"Endocr Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1298628","article-title":"Predicting polycystic ovary syndrome with machine learning algorithms from electronic health records","volume":"15","author":"Zad Z","year":"2024","unstructured":"Zad Z, Jiang VS, Wolf AT, Wang T, Cheng JJ, Paschalidis IC, Mahalingaiah S. Predicting polycystic ovary syndrome with machine learning algorithms from electronic health records. Front Endocrinol (Lausanne). 2024, 15:1298628. 10.3389\/fendo.2024.1298628","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081506","article-title":"Polycystic ovary syndrome detection machine learning model based on optimized feature selection and explainable artificial intelligence","volume":"13","author":"Elmannai H","year":"2023","unstructured":"Elmannai H, El-Rashidy N, Mashal I, Alohali MA, Farag S, El-Sappagh S, Saleh H. Polycystic ovary syndrome detection machine learning model based on optimized feature selection and explainable artificial intelligence. Diagnostics (Basel). 2023, 13:1506. 10.3390\/diagnostics13081506","journal-title":"Diagnostics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/3093","article-title":"Polycystic ovary syndrome diagnosis: the promise of artificial intelligence for improved clinical accuracy","volume":"18","author":"Upreti K","year":"2025","unstructured":"Upreti K, George J, Upreti S, Mahajan S. Polycystic ovary syndrome diagnosis: the promise of artificial intelligence for improved clinical accuracy. Biomed Pharmocol J. 2025, 18:353-72. 10.13005\/bpj\/3093","journal-title":"Biomed Pharmocol J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408661-a-retrospective-study-for-the-evaluation-of-serum-anti-mllerian-hormone-and-its-correlation-with-insulin-resistance-and-lipid-profile-in-polycystic-ovary-syndrome-in-adolescents","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:41Z","timestamp":1760186561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408661-a-retrospective-study-for-the-evaluation-of-serum-anti-mllerian-hormone-and-its-correlation-with-insulin-resistance-and-lipid-profile-in-polycystic-ovary-syndrome-in-adolescents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.94344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}